唾液采集与诊断市场、机会、成长动力、产业趋势分析与预测，2024-2032

由于非侵入性唾液测试作为传统诊断方法的便捷且可接受的替代方案的吸引力日益增长，全球唾液采集和诊断市场将在 2024 年至 2032 年间呈现 8.3% 的复合年增长率。据美国国立卫生研究院（NIH）称，由于其便利性和准确性，包括基于唾液的检测在内的非侵入性诊断技术将从2023年到2028年以每年9.5%的速度增长。

此外，慢性病盛行率的不断上升以及对早期疾病检测的需求不断增加，也促进了唾液诊断的采用。家庭检测的便利性和对个人化医疗的日益关注支持了市场的扩张。

唾液采集和诊断市场根据采集地点、应用、最终用途和地区进行分类。

在研究期间，腮腺采集部分将以显着的速度增长，与其他采集点相比，由于诊断率更高，腮腺采集部分将显着增长。腮腺产生较高浓度的某些生物标记物，提高了诊断测试的敏感性和特异性。这种改进的诊断效能对于准确检测和监测各种健康状况（包括口腔疾病和全身性疾病）至关重要。此外，对精准医学的日益重视正在推动更准确、更可靠的诊断方法，进一步提高了对腮腺采集的偏好。

由于其在刑事调查和法律诉讼中的关键作用，到 2032 年，法医学领域将在唾液采集和诊断市场中占据重要份额。唾液样本用于 DNA 分析，这对于识别嫌疑人和受害者以及在法医案件中建立关係至关重要。唾液采集的非侵入性，加上其提供有价值的遗传资讯的能力，使其成为法医学的首选方法。人们越来越依赖基于唾液的诊断来获取准确可靠的证据，这正在促进法医技术的进步，增加细分市场的份额。

在对医疗保健创新和以患者为中心的解决方案的关注推动下，到 2032 年，欧洲唾液采集和诊断市场将以惊人的速度成长。欧洲国家正在投资研发工作，以增强诊断技术，促进非侵入性检测方法的进步。此外，慢性病盛行率的上升和对早期疾病检测的推动推动了对更容易获得的诊断工具的需求。诊断研究的支持性监管框架和资助计划促进了市场成长。欧洲个人化医疗的成长趋势将推动产业动态向前发展。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 人口中传染病的增加
    • 对非侵入性唾液检测替代血液检测的需求不断增长
    • 技术进步
  • 产业陷阱与挑战
    • 缺乏熟练的专业人员来操作唾液收集设备
• 成长潜力分析
• 报销场景
• 监管环境
• 新兴疗法
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按收集地点，2021 - 2032 年

• 主要趋势
• 腮腺
• 下颔腺/舌下腺
• 小唾液腺

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 疾病诊断
  • 传染病
  • 基因检测
  • 其他疾病诊断
• 法证学
• 研究

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 医院和牙科诊所
• 诊断实验室
• 製药和生物技术公司
• 研究所
• 法医实验室

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Abbott Laboratories
• Akonni Biosystems, Inc.
• Autogen, Inc.
• Meridian Bioscience, Inc.
• Neogen Inc
• Norgen Biotek Corp
• OraSure Technologies, Inc
• Porex
• Salimetrics, LLC.
• Sarstedt AG and Co.KG
• Spectrum Solutions, LLC.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Wuxi NEST Biotechnology Co., Ltd
• ZRT Laboratory
• Zymo Research Corporation

The Global Saliva Collection and Diagnostics Market will showcase an 8.3% CAGR between 2024 and 2032, driven by the growing appeal of non-invasive saliva-based tests as a convenient and acceptable alternative to traditional diagnostic methods. According to the U.S. National Institutes of Health (NIH), non-invasive diagnostic technologies, including saliva-based tests, will grow at an annual rate of 9.5% from 2023 to 2028 due to their convenience and accuracy.

Additionally, the increasing prevalence of chronic diseases and the rising demand for early disease detection are bolstering the adoption of saliva diagnostics. The convenience of at-home testing and the growing focus on personalized medicine supports market expansion.

The saliva collection and diagnostics market is sorted based on the site of collection, application, end-use, and region.

The parotid gland collection segment will grow at a notable pace over the study period, driven by superior diagnostic yield compared to other collection sites. The parotid gland produces a higher concentration of certain biomarkers, which enhances the sensitivity and specificity of diagnostic tests. This improved diagnostic performance is crucial for accurately detecting and monitoring various health conditions, including oral diseases and systemic disorders. Additionally, the growing emphasis on precision medicine is pushing for more accurate and reliable diagnostic methods, further boosting the preference for parotid gland collection.

The forensics segment will hold a significant share of the saliva collection and diagnostics market by 2032, owing to its critical role in criminal investigations and legal proceedings. Saliva samples are used for DNA analysis, which is essential for identifying suspects, and victims, and establishing relationships in forensic cases. The non-invasive nature of saliva collection, combined with its ability to provide valuable genetic information, makes it a preferred method in forensic science. This rising reliance on saliva-based diagnostics for accurate and reliable evidence is promoting advancements in forensic technologies, adding to segment share.

Europe saliva collection and diagnostics market will grow at an impressive pace through 2032, driven by the focus on healthcare innovation and patient-centric solutions. European countries are investing in R and D efforts to enhance diagnostic technologies, fostering advancements in non-invasive testing methods. Additionally, the rising prevalence of chronic diseases and the push for early disease detection are fueling demand for more accessible diagnostic tools. Supportive regulatory frameworks and funding initiatives for diagnostic research bolster market growth. The growing trend towards personalized medicine in Europe will sway the industry dynamics forward.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing infectious diseases among the population
    • 3.2.1.2 Rising demand for non-invasive saliva testing as a replacement of blood testing
    • 3.2.1.3 Technological advancements
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled professionals to operate saliva collection devices
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 New emerging therapies
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Site of Collection, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Parotid gland
• 5.3 Submandibular/Sublingual gland
• 5.4 Minor salivary glands

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Disease diagnostics
  • 6.2.1 Infectious diseases
  • 6.2.2 Genetic testing
  • 6.2.3 Other disease diagnostics
• 6.3 Forensics
• 6.4 Research

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Hospitals and dental clinics
• 7.2 Diagnostic laboratories
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Research Institutes
• 7.5 Forensic laboratories

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Akonni Biosystems, Inc.
• 9.3 Autogen, Inc.
• 9.4 Meridian Bioscience, Inc.
• 9.5 Neogen Inc
• 9.6 Norgen Biotek Corp
• 9.7 OraSure Technologies, Inc
• 9.8 Porex
• 9.9 Salimetrics, LLC.
• 9.10 Sarstedt AG and Co.KG
• 9.11 Spectrum Solutions, LLC.
• 9.12 Takara Bio, Inc.
• 9.13 Thermo Fisher Scientific, Inc.
• 9.14 Wuxi NEST Biotechnology Co., Ltd
• 9.15 ZRT Laboratory
• 9.16 Zymo Research Corporation